Effects of Zinc Phthalocyanine Photodynamic Therapy on Vital Structures and Processes in Hela Cells

Jakub Hosik1, Barbora Hosikova1, Svatopluk Binder1

  • 1Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University, 77900 Olomouc, Czech Republic.

Insights

Newly developed zinc phthalocyanine photodynamic therapy (ZnPc PDT) effectively targets cancer cells. This promising antitumoral treatment shows significant cell damage and low effective concentration, indicating potential for cancer therapy.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Photodynamic Therapy

Background:

  • Photodynamic therapy (PDT) is an emerging cancer treatment modality.
  • Zinc phthalocyanines (ZnPc) are photosensitizers used in PDT.
  • Understanding the cellular mechanisms of ZnPc PDT is crucial for optimizing its efficacy.

Purpose of the Study:

  • To evaluate the efficiency of a novel zinc phthalocyanine-mediated photodynamic therapy (ZnPc PDT).
  • To investigate the mechanistic and cell biological effects of ZnPc PDT on tumoral and nontumoral cell models.
  • To assess the potential of ZnPc PDT as an antitumoral treatment.

Main Methods:

  • MTT assay for cell viability assessment.
  • Analysis of reactive oxygen species (ROS) production.
  • Measurement of mitochondrial membrane potential.
  • Determination of genotoxicity and DNA fragmentation.
  • Capillary chromatography and tandem mass spectrometry (ESI-MS/MS) for protein analysis.

Main Results:

  • ZnPc PDT significantly increased ROS production in vitro.
  • Significant damage to mitochondrial membranes was observed (70% decrease in VDAC1, 65% change in mitochondrial membrane potential).
  • Increased DNA fragmentation and decreased DDB1 levels indicated genotoxicity.
  • Low effective concentration (LC50 = 30 nM) was determined.

Conclusions:

  • ZnPc PDT demonstrates significant efficacy in damaging cancer cells through ROS generation and mitochondrial dysfunction.
  • The therapy induces genotoxicity, potentially through DDB1 downregulation.
  • The low effective concentration and observed cellular damage highlight ZnPc PDT as a promising antitumoral strategy.